Reviews | We can cure disease by modifying a person’s DNA. Why aren’t we?
Across the sector of for-profit companies that manufacture gene therapy drugs, a sobering process is taking place. Even when they create a treatment that works, companies price it exorbitantly (about $2-3 million per patient), arguing that a one-time treatment saves the healthcare system years of supportive care. expensive. For diseases with less than 100 patients, …
Reviews | We can cure disease by modifying a person’s DNA. Why aren’t we? Read More »
